Adverse Effect of Nano-Silicon Dioxide on Lung Function of Rats with or without Ovalbumin Immunization

Bing Han, Jing Guo, Tesfamariam Abrahaley, Longjuan Qin, Li Wang, Yuduo Zheng, Bing Li, Dandan Liu, Hanchao Yao, Jiwen Yang, Chang Ming Li, Zhuge Xi, Xu YangPLoS 2011 · DOI

Abstract

This preliminary study investigated the effects of nano-silicon dioxide ($SiO_2$) on an ovalbumin (OVA)-induced rat asthma model. The results demonstrate that intratracheal administration of nano-$SiO_2$ leads to airway hyperresponsiveness (AHR) and airway remodeling, regardless of OVA immunization status. This pathology appears to be driven by a Th1/Th2 cytokine imbalance, specifically an increase in tissue IL-4 production accelerated by nanoparticle exposure.

Introduction

Silicon dioxide ($SiO_2$) nanoparticles, typically ranging from 10 to 20 nm, are among the most widely utilized nanomaterials in modern industry, appearing in applications ranging from microelectronics and consumer products to biomedical engineering. Despite their utility, the potential for "nanotoxicity" poses a significant public health question. While the dangers of bulk silica dust (silicosis) are well-documented, the specific impact of nanoparticles on the respiratory system—especially when interacting with pre-existing conditions like allergic asthma—remains a critical safety gap. This study sought to bridge this gap by examining how nano-$SiO_2$ influences lung function and immune signaling in a sensitized animal model.

Methods

The researchers employed a male Wistar rat model, dividing 54 subjects into six experimental groups ($n=9$ per group). These groups were designed to compare the effects of asthma induction (via ovalbumin immunization) against varying levels of nanoparticle exposure. The $SiO_2$ nanoparticles (10–20 nm) were administered via daily intratracheal instillation at concentrations of 0, 40, and 80 mg/ml over a 30-day period.

To assess respiratory health, the team utilized the AniRes2005 lung function system. They measured inspiratory resistance (Ri), expiratory resistance (Re), and dynamic compliance (Cldyn) following a methacholine challenge, a standard procedure for evaluating airway hyperresponsiveness. Following physiological testing, Bronchoalveolar Lavage (BAL) was performed to quantify inflammatory cell populations. Cytokine levels, specifically Interleukin-4 (IL-4) and Interferon-gamma (IFN-$\gamma$), were measured using ELISA to determine the state of the Th1/Th2 immune balance. Finally, lung tissues underwent histological staining (H&E) to visualize physical remodeling.

Results

The study yielded several key insights into the physiological and biochemical impacts of nano-$SiO_2$:

Airway Hyperresponsiveness (AHR)

High-dose $SiO_2$ exposure (80 mg/ml) resulted in a significant increase in both inspiratory and expiratory resistance ($p < 0.01$). This effect was observed in both the OVA-immunized and saline-control groups, though it was most severe in the asthmatic model. Interestingly, dynamic compliance (Cldyn) showed no significant change, suggesting that the nanoparticles primarily affected the larger airways rather than the deep lung parenchyma.

Cytokine Imbalance

A critical finding was the shift in the Th1/Th2 cytokine ratio. In the 80 mg/ml exposure groups, IL-4 levels—a hallmark of the Th2 allergic response—were significantly elevated. Conversely, IFN-$\gamma$ levels, which typically represent a protective Th1 response, showed a declining trend. This suggests that nano-$SiO_2$ acts as an adjuvant, exacerbating the allergic inflammatory pathway by shifting the immune "teeter-totter."

Airway Remodeling

Histological examination confirmed physical damage to the lung architecture. Rats in the high-dose groups exhibited clear signs of wall thickening, mucous metaplasia, and subepithelial fibrosis. These changes were present even in non-asthmatic rats, indicating that high concentrations of nano-$SiO_2$ are inherently damaging to lung tissue. Group F (OVA + 80 mg/ml $SiO_2$) showed the most severe degradation across all histological markers.

The Eosinophil Paradox

Contrary to expectations for a standard asthma model, higher $SiO_2$ exposure was associated with a lower percentage of eosinophils in the BAL fluid. The authors speculate this might indicate a shift toward a "noneosinophilic" asthma phenotype or perhaps a side effect of the intensive 30-day instillation protocol.

Discussion

The results indicate that nano-$SiO_2$ exposure poses a dual threat: it directly damages airway structures and indirectly worsens allergic conditions by modulating the immune system. The observed Th1/Th2 imbalance, characterized by increased IL-4, provides a biochemical explanation for the increased airway resistance. The fact that remodeling occurred in non-sensitized rats suggests that the toxicity of $SiO_2$ nanoparticles is not solely dependent on an underlying allergy, though the allergy certainly compounds the damage.

One notable observation was the focus of resistance changes in the large airways. This suggests that the delivery method or the physical properties of the nanoparticles in suspension may limit their impact on the small airways or deep lung tissue in this specific model. Future work using aerosolized delivery systems would be beneficial to better mimic real-world inhalation exposure and to identify the "No Observed Adverse Effect Level" (NOAEL) for different nanoparticle sizes.

Conclusion

This research demonstrates that nano-$SiO_2$ can significantly exacerbate airway hyperresponsiveness and remodeling in an asthma model. By shifting the immune response toward a Th2-dominated profile, these nanoparticles increase the severity of allergic airway disease. These findings emphasize the importance of establishing safety thresholds and protective measures for individuals exposed to nanomaterials, particularly those with pre-existing respiratory vulnerabilities.

Summary updated

Abstract

This was a preliminary study which for the first time involved the effect of nano-SiO₂ to OVA induced rat asthma model. The results suggested that intratracheal administration of nano-SiO₂ could lead to the airway hyperresponsiveness (AHR) and the airway remolding with or without OVA immunization. This occurrence may be due to the Th1/Th2 cytokine imbalance accelerated by the nano-SiO₂ through increasing the tissue IL-4 production.
BibTeX
@inproceedings{han2011adverse,
  author = {Bing Han and Jing Guo and Tesfamariam Abrahaley and Longjuan Qin and Li Wang and Yuduo Zheng and Bing Li and Dandan Liu and Hanchao Yao and Jiwen Yang and Chang Ming Li and Zhuge Xi and Xu Yang},
  title = {{Adverse Effect of Nano-Silicon Dioxide on Lung Function of Rats with or without Ovalbumin Immunization}},
  booktitle = {PLoS},
  year = {2011},
  doi = {10.1371/journal.pone.0017236},
}
Figure